IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
PKP3 | Plakophilin 3 | Plasma proteins
| | | | | Tissue enhanced |
TALDO1 | Transaldolase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
STIM1 | Stromal interaction molecule 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TRIM21 | Tripartite motif containing 21 | Plasma proteins
| | | | | Expressed in all |
TAF10 | TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa | | | | | | Expressed in all |
COPB1 | Coatomer protein complex, subunit beta 1 | Plasma proteins
| | | | | Expressed in all |
PSMA1 | Proteasome (prosome, macropain) subunit, alpha type, 1 | Enzymes
| | | | | Expressed in all |
GTF2H1 | General transcription factor IIH, polypeptide 1, 62kDa | Cancer-related genes
| | | | | Expressed in all |
TSG101 | Tumor susceptibility 101 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RCN1 | Reticulocalbin 1, EF-hand calcium binding domain | Predicted secreted proteins
| | | | | Expressed in all |
EIF3M | Eukaryotic translation initiation factor 3, subunit M | | | | | | Expressed in all |
CSTF3 | Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa | | | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ARHGAP1 | Rho GTPase activating protein 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
PSMC3 | Proteasome (prosome, macropain) 26S subunit, ATPase, 3 | Plasma proteins
| | | | | Expressed in all |
CELF1 | CUGBP, Elav-like family member 1 | Plasma proteins
| | | | | Expressed in all |
TNKS1BP1 | Tankyrase 1 binding protein 1, 182kDa | Cytoskeleton related proteins
| | | | | Expressed in all |
CLP1 | Cleavage and polyadenylation factor I subunit 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CTNND1 | Catenin (cadherin-associated protein), delta 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LPXN | Leupaxin | | | | | | Expressed in all |
CCDC86 | Coiled-coil domain containing 86 | | | | | | Expressed in all |
PRPF19 | Pre-mRNA processing factor 19 | Plasma proteins
| | | | | Expressed in all |
AHNAK | AHNAK nucleoprotein | Plasma proteins
| | | | | Expressed in all |
MTA2 | Metastasis associated 1 family, member 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RTN3 | Reticulon 3 | Predicted membrane proteins
| | | | | Expressed in all |
STIP1 | Stress-induced-phosphoprotein 1 | Plasma proteins
| | | | | Expressed in all |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | | Group enriched |
PRDX5 | Peroxiredoxin 5 | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
RPS6KA4 | Ribosomal protein S6 kinase, 90kDa, polypeptide 4 | Enzymes Plasma proteins
| | | | | Expressed in all |
ZFPL1 | Zinc finger protein-like 1 | Predicted membrane proteins
| | | | | Expressed in all |
SYVN1 | Synovial apoptosis inhibitor 1, synoviolin | Predicted membrane proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
SIPA1 | Signal-induced proliferation-associated 1 | | | | | | Expressed in all |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
PC | Pyruvate carboxylase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
SSH3 | Slingshot protein phosphatase 3 | Cytoskeleton related proteins Enzymes
| | | | | Expressed in all |
AIP | Aryl hydrocarbon receptor interacting protein | Disease related genes Plasma proteins
| | | | | Expressed in all |
GSTP1 | Glutathione S-transferase pi 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
PPP6R3 | Protein phosphatase 6, regulatory subunit 3 | | | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets
| | | | | Mixed |
FADD | Fas (TNFRSF6)-associated via death domain | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NUMA1 | Nuclear mitotic apparatus protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LAMTOR1 | Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | | | | | | Expressed in all |
ARRB1 | Arrestin, beta 1 | | | | | | Expressed in all |